Divi's Laboratories Limited (NSE: DIVISLAB) is a pharmaceutical company specializing in the manufacture of active pharmaceutical ingredients (APIs) and intermediates. The company
Search Results for: NSE:DIVISLAB
Divi’s Laboratories Ltd (DIVISLAB) Q1 FY23 Earnings Concall Transcript
Divi's Laboratories Ltd (NSE:DIVISLAB) Q1 FY23 Earnings Concall dated Aug. 12, 2022 Corporate Participants: Satish Choudhury -- Company Secretary and Chief Investor
Divi’s Laboratories Ltd (DIVISLAB) Q2 FY22 Earnings Concall Transcript
Divi's Laboratories Ltd (NSE:DIVISLAB) Q2 FY22 Earnings Concall dated Nov. 06, 2021. Corporate Participants: M. Satish Choudhury -- Company Secretary & Compliance Officer